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in both testicular and prostatic tumours.
and the extensive discussion between sections
is particularly useful for tying together the
different assays and opposing views.
Other topics well covered are in the section
on animal models and attempts at demon-
strating specific antitumour immunity. From
the clinical point of viewi the section on
immunotherapy clearly indicates that little
has yet been achieved, but as none of the
studies reported had more than 20 patients,
the positive results in the studies of BCG
in bladder and kidney tumour did provide
some encouragement.
The final section relates to studies of
tumour regression after cryosurgery to the
prostate. In a disease where chemotherapy
has contributed little, this approach obviouslv
deserves further evaluation.
This book may prove of value to reference
libraries in centres with major urological
departments.
R. T. D. OLIVER
Progress in Experimental Tumour
Research Vol 25: Current Cancer
Immunology. (Ed) V. RICHARDS (1980).
Basel: Karger. 296 pp. US$87.00.
Progress is an optimist's word for change.
This excellent series of books returns once
again (the 3rd time in 25 volumes) to tumour
immunology, to document recent changes in
the topic. The emphasis of this volume is on
the clinical achievements of tumour immuno-
logy, and consequently it provides few signs
of anything that even an optimist would call
progress.
In the first 60 pages Dr Victor Richards
attempts the impossible by trying to sum-
marize the whole of immunology in a chapter
which he calls an "overview". This results,
as one might expect, in oversights. Proof-
reading errors are abundant (e.g. "homograft
resection" and 'anti-idiopathiccells"). Theuse
of outdated terminology and his enthusiasm
for blocking factors conveys a powerful
sense of deja vu. He states with confidence
(on p. 26) that every human neoplasm,
adequately studied, contains specific antigens
which elicit host responses. He may well be
right, but such an uncritical acceptance of
inadequate data is surprising. Ending, of
course, on a note of exuberant optimism he
tells us (in a cliche repeated by other con-
tributors) that 'immunotherapy of human
cancer is in its infancy". This remarkable
case of arrested development is clearly
documented in the rest of the book.
Apart from a useful section written by the
Montreal group on immunological methods
of diagnosis, the rest are familiar and opti-
mistic accounts of immunotherapy. Between
them the various authors weave a web of
Byzantine complexity in their attempts to
convince us thatimmunotherapyis, orisabout
to become, an effective form of treatment.
Much ofthe evidence presented ofthe benefits
of BCG, transfer factor, immune RNA,
levamisole and specific antibodies is poorly
controlled, and any attempt by your humble
reviewer to detail the inadequacies of these
studies would undoubtedly attract the atten-
tions of Koestler's Society for the Prevention
of Cruelty to Dead Horses.
By concentrating on the clinical aspects of
tumour immunology this disappointing book
might lead one to suppose that there has
been little progress in this subject over the
past 10 years. There have been substantial
changes, but then, change is a pessimist's
word for progress.
G. A. CURRIE
Malignancies of the Ovary, Uterus and
Cervix. R. S. BUSH(1979). London: Arnold.
243 pp. £13.95.
This is the second book in a 'Management
ofMalignant Disease Series" and is concerned
with those aspects ofthe major gynaecological
malignancies which contribute to the final
decisions about treatment. Dr Bush starts
with a very necessary discussion on "End
points for evaluating treatment" that will
be of benefit to anyone not working directly
in the onocological field.
The body of the text is devoted to the 3
major gynaecological malignancies, carcino-
mas of the ovary, uterine body and cervix,
and they are presented in the standard form:
natural history, evaluation and management.
There is no attempt to go into the technical
details of the surgical and radiotherapeutic
treatments involved, except where these
relate to the different management schemes.
In tackling these difficult subjects the
author manages to present well reasoned
arguments that lead to an understanding of
the Princess Margaret approach. The text